- Home
- BHE vs ATRC Comparison
BHE vs ATRC Comparison
Compare BHE & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHE
- ATRC
- Stock Information
- Founded
- BHE 1979
- ATRC 2000
- Country
- BHE United States
- ATRC United States
- Employees
- BHE N/A
- ATRC N/A
- Industry
- BHE Electrical Products
- ATRC Medical/Dental Instruments
- Sector
- BHE Technology
- ATRC Health Care
- Exchange
- BHE Nasdaq
- ATRC Nasdaq
- Market Cap
- BHE 1.6B
- ATRC 1.6B
- IPO Year
- BHE 1990
- ATRC 2005
- Fundamental
- Price
- BHE $42.65
- ATRC $33.13
- Analyst Decision
- BHE Strong Buy
- ATRC Strong Buy
- Analyst Count
- BHE 2
- ATRC 9
- Target Price
- BHE $46.50
- ATRC $52.00
- AVG Volume (30 Days)
- BHE 315.0K
- ATRC 618.7K
- Earning Date
- BHE 11-04-2025
- ATRC 10-29-2025
- Dividend Yield
- BHE 1.59%
- ATRC N/A
- EPS Growth
- BHE N/A
- ATRC N/A
- EPS
- BHE 1.02
- ATRC N/A
- Revenue
- BHE $2,611,664,000.00
- ATRC $518,304,999.00
- Revenue This Year
- BHE $0.03
- ATRC $16.90
- Revenue Next Year
- BHE $5.83
- ATRC $12.29
- P/E Ratio
- BHE $41.97
- ATRC N/A
- Revenue Growth
- BHE N/A
- ATRC 15.80
- 52 Week Low
- BHE $30.73
- ATRC $28.29
- 52 Week High
- BHE $50.26
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- BHE 49.03
- ATRC 45.22
- Support Level
- BHE $42.10
- ATRC $31.12
- Resistance Level
- BHE $45.80
- ATRC $33.98
- Average True Range (ATR)
- BHE 1.51
- ATRC 1.80
- MACD
- BHE -0.37
- ATRC -0.00
- Stochastic Oscillator
- BHE 11.20
- ATRC 39.16
About BHE Benchmark Electronics Inc.
Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.